Skip to main content
GeneOne Life Science, Inc. logo

GeneOne Life Science, Inc. — Investor Relations & Filings

Ticker · 011000 ISIN · KR7011000007 KO Professional, scientific and technical activities
Open in API
Filings indexed 490 across all filing types
Latest filing 2024-11-28 Proxy Solicitation & In…
Country KR South Korea
Listing KO 011000

About GeneOne Life Science, Inc.

https://www.genels.com/en/

GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used to solicit shareholder votes for an upcoming general meeting. It contains details about the meeting agenda (such as changes to the articles of incorporation, election of directors, and auditors), information about the solicitors, and instructions for electronic or written voting. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2024-11-28 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (임시주주총회 소집공고) issued by GeneOne Life Science (진원생명과학). It includes details about the meeting date, location, agenda items (such as board appointments and articles of association changes), and voting procedures (including electronic voting). This document is a standard proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and request their participation/votes. It is not a report publication announcement, as it contains the full meeting agenda and proxy materials.
2024-11-28 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for GeneOne Life Science, Inc. covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from a Korean company (GeneOne Life Science) regarding the signing of a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty, duration, and terms. Since this is a specific regulatory announcement of a material business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2024-10-30 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for Jin-Won Life Science, detailing the date, location, and agenda items (such as articles of incorporation changes and director/auditor appointments). This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2024-10-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the setting of a record date for an Extraordinary General Meeting of Shareholders. It is a standard corporate announcement regarding shareholder rights and meeting preparation, which falls under the general regulatory filing category as it does not fit into specific categories like dividend announcements or proxy solicitations.
2024-10-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.